US Stock MarketDetailed Quotes

Sionna Therapeutics (SION)

Watchlist
  • 43.120
  • +2.180+5.32%
Close May 13 16:00 ET
1.95BMarket Cap-22.69P/E (TTM)

Sionna Therapeutics (SION) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-34.09%-21.84M
-25.59%-66.3M
-41.13%-16.63M
13.89%-15.23M
-78.94%-18.15M
-23.63%-16.29M
-20.80%-52.79M
-58.09%-11.78M
-17.69M
-10.15M
Net income from continuing operations
-62.47%-26.78M
-22.01%-75.27M
-28.98%-20.44M
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
---25.44M
---8.55M
Depreciation and amortization
-3.14%154K
-3.14%647K
-8.98%152K
11.83%189K
-11.45%147K
-4.22%159K
14.58%668K
3.73%167K
--169K
--166K
Other non cash items
-0.41%489K
-81.49%1.96M
0.20%491K
-94.63%490K
0.00%490K
-0.20%491K
385.39%10.6M
-21.85%490K
--9.13M
--490K
Change In working capital
-11.01%-2.06M
13.76%-2.65M
-109.63%-302K
220.80%1.9M
-13.18%-2.4M
26.53%-1.85M
-292.72%-3.08M
0.55%3.14M
---1.57M
---2.12M
-Change in prepaid assets
232.38%740K
24.57%-2.08M
-163.98%-1.54M
125.04%177K
29.07%-161K
55.03%-559K
-928.83%-2.76M
-227.29%-583K
---707K
---227K
-Change in payables and accrued expense
-194.26%-2.25M
0.71%1.56M
-58.18%1.78M
715.03%2.25M
-22.72%-1.71M
19.54%-766K
263.88%1.55M
52.44%4.26M
---366K
---1.39M
-Change in other current assets
----
--0
--0
--0
--0
--0
--35K
---9K
--15K
--14K
-Change in other current liabilities
-2.84%-543K
-12.18%-2.13M
-2.84%-543K
-2.92%-529K
-2.92%-528K
-54.39%-528K
-1,002.91%-1.9M
-303.05%-528K
---514K
---513K
Cash from discontinued investing activities
Operating cash flow
-34.09%-21.84M
-25.59%-66.3M
-41.13%-16.63M
13.89%-15.23M
-78.94%-18.15M
-23.63%-16.29M
-20.80%-52.79M
-58.09%-11.78M
---17.69M
---10.15M
Investing cash flow
Cash flow from continuing investing activities
117.58%24.82M
6.43%-118.75M
48.33%22.59M
121.99%23.1M
18.78%-23.25M
-13.93%-141.19M
-564.00%-126.91M
113.64%15.23M
10.41M
-28.62M
Net PPE purchase and sale
--0
-1,296.30%-377K
-655.56%-204K
---87K
--0
---86K
97.58%-27K
77.87%-27K
--0
--0
Net investment purchase and sale
117.59%24.82M
6.71%-118.37M
49.41%22.79M
122.82%23.19M
18.78%-23.25M
-13.86%-141.11M
-545.71%-126.89M
110.41%15.26M
--10.41M
---28.62M
Cash from discontinued investing activities
Investing cash flow
117.58%24.82M
6.43%-118.75M
48.33%22.59M
121.99%23.1M
18.78%-23.25M
-13.93%-141.19M
-564.00%-126.91M
113.64%15.23M
--10.41M
---28.62M
Financing cash flow
Cash flow from continuing financing activities
-99.06%1.89M
14.94%205.71M
217.83%1.66M
298.19%1.97M
-921.05%-312K
11.61%202.39M
577,212.90%178.97M
-1.41M
-996K
38K
Net common stock issuance
--0
--202.07M
--0
--0
---318K
--202.39M
--0
--0
--0
--0
Net preferred stock issuance
----
--0
--0
--0
--0
--0
--181.33M
--0
--0
--0
Proceeds from stock option exercised by employees
--2.21M
2,480.85%3.64M
6,536.00%1.66M
2,604.11%1.97M
-84.21%6K
--0
354.84%141K
--25K
--73K
--38K
Net other financing activities
---320K
----
----
----
----
----
---2.5M
---1.43M
----
----
Cash from discontinued financing activities
Financing cash flow
-99.06%1.89M
14.94%205.71M
217.83%1.66M
298.19%1.97M
-921.05%-312K
11.61%202.39M
577,212.90%178.97M
---1.41M
---996K
--38K
Net cash flow
Beginning cash position
53.33%59.41M
-1.86%38.75M
41.08%51.79M
-6.76%41.95M
-0.07%83.66M
-1.86%38.75M
-29.24%39.48M
-7.78%36.71M
--44.99M
--83.71M
Current changes in cash
-89.15%4.87M
2,919.10%20.66M
273.76%7.62M
218.98%9.85M
-7.70%-41.71M
1.53%44.91M
95.51%-733K
729.32%2.04M
---8.28M
---38.73M
End cash Position
-23.15%64.29M
53.33%59.41M
53.33%59.41M
41.08%51.79M
-6.76%41.95M
-0.07%83.66M
-1.86%38.75M
-1.86%38.75M
--36.71M
--44.99M
Free cash flow
-33.38%-21.84M
-26.24%-66.67M
-42.53%-16.83M
13.39%-15.32M
-78.94%-18.15M
-24.28%-16.37M
-17.85%-52.81M
-55.90%-11.81M
---17.69M
---10.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -34.09%-21.84M-25.59%-66.3M-41.13%-16.63M13.89%-15.23M-78.94%-18.15M-23.63%-16.29M-20.80%-52.79M-58.09%-11.78M-17.69M-10.15M
Net income from continuing operations -62.47%-26.78M-22.01%-75.27M-28.98%-20.44M20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M---25.44M---8.55M
Depreciation and amortization -3.14%154K-3.14%647K-8.98%152K11.83%189K-11.45%147K-4.22%159K14.58%668K3.73%167K--169K--166K
Other non cash items -0.41%489K-81.49%1.96M0.20%491K-94.63%490K0.00%490K-0.20%491K385.39%10.6M-21.85%490K--9.13M--490K
Change In working capital -11.01%-2.06M13.76%-2.65M-109.63%-302K220.80%1.9M-13.18%-2.4M26.53%-1.85M-292.72%-3.08M0.55%3.14M---1.57M---2.12M
-Change in prepaid assets 232.38%740K24.57%-2.08M-163.98%-1.54M125.04%177K29.07%-161K55.03%-559K-928.83%-2.76M-227.29%-583K---707K---227K
-Change in payables and accrued expense -194.26%-2.25M0.71%1.56M-58.18%1.78M715.03%2.25M-22.72%-1.71M19.54%-766K263.88%1.55M52.44%4.26M---366K---1.39M
-Change in other current assets ------0--0--0--0--0--35K---9K--15K--14K
-Change in other current liabilities -2.84%-543K-12.18%-2.13M-2.84%-543K-2.92%-529K-2.92%-528K-54.39%-528K-1,002.91%-1.9M-303.05%-528K---514K---513K
Cash from discontinued investing activities
Operating cash flow -34.09%-21.84M-25.59%-66.3M-41.13%-16.63M13.89%-15.23M-78.94%-18.15M-23.63%-16.29M-20.80%-52.79M-58.09%-11.78M---17.69M---10.15M
Investing cash flow
Cash flow from continuing investing activities 117.58%24.82M6.43%-118.75M48.33%22.59M121.99%23.1M18.78%-23.25M-13.93%-141.19M-564.00%-126.91M113.64%15.23M10.41M-28.62M
Net PPE purchase and sale --0-1,296.30%-377K-655.56%-204K---87K--0---86K97.58%-27K77.87%-27K--0--0
Net investment purchase and sale 117.59%24.82M6.71%-118.37M49.41%22.79M122.82%23.19M18.78%-23.25M-13.86%-141.11M-545.71%-126.89M110.41%15.26M--10.41M---28.62M
Cash from discontinued investing activities
Investing cash flow 117.58%24.82M6.43%-118.75M48.33%22.59M121.99%23.1M18.78%-23.25M-13.93%-141.19M-564.00%-126.91M113.64%15.23M--10.41M---28.62M
Financing cash flow
Cash flow from continuing financing activities -99.06%1.89M14.94%205.71M217.83%1.66M298.19%1.97M-921.05%-312K11.61%202.39M577,212.90%178.97M-1.41M-996K38K
Net common stock issuance --0--202.07M--0--0---318K--202.39M--0--0--0--0
Net preferred stock issuance ------0--0--0--0--0--181.33M--0--0--0
Proceeds from stock option exercised by employees --2.21M2,480.85%3.64M6,536.00%1.66M2,604.11%1.97M-84.21%6K--0354.84%141K--25K--73K--38K
Net other financing activities ---320K-----------------------2.5M---1.43M--------
Cash from discontinued financing activities
Financing cash flow -99.06%1.89M14.94%205.71M217.83%1.66M298.19%1.97M-921.05%-312K11.61%202.39M577,212.90%178.97M---1.41M---996K--38K
Net cash flow
Beginning cash position 53.33%59.41M-1.86%38.75M41.08%51.79M-6.76%41.95M-0.07%83.66M-1.86%38.75M-29.24%39.48M-7.78%36.71M--44.99M--83.71M
Current changes in cash -89.15%4.87M2,919.10%20.66M273.76%7.62M218.98%9.85M-7.70%-41.71M1.53%44.91M95.51%-733K729.32%2.04M---8.28M---38.73M
End cash Position -23.15%64.29M53.33%59.41M53.33%59.41M41.08%51.79M-6.76%41.95M-0.07%83.66M-1.86%38.75M-1.86%38.75M--36.71M--44.99M
Free cash flow -33.38%-21.84M-26.24%-66.67M-42.53%-16.83M13.39%-15.32M-78.94%-18.15M-24.28%-16.37M-17.85%-52.81M-55.90%-11.81M---17.69M---10.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More